Systemic Sclerosis (Scleroderma) and SSDI

You can qualify for Social Security Disability Insurance (SSDI) with systemic sclerosis, commonly known as scleroderma, if your condition satisfies Blue Book Listing 14.04 or prevents you from working. The Social Security Administration (SSA) evaluates this connective tissue disorder based on documented skin changes, digital ischemia from Raynaud's phenomenon, internal organ damage, or frequent systemic flares under 20 CFR Part 404, Subpart P, Appendix 1.

Scleroderma is an autoimmune disorder causing excess collagen buildup in the skin and internal organs. The condition ranges from localized skin thickening to diffuse systemic sclerosis affecting the lungs, heart, kidneys, and digestive tract. To receive disability benefits, you must demonstrate that your condition causes severe, lasting limitations that prevent you from sustaining substantial gainful work.

Establishing a Medically Determinable Impairment

Before SSA evaluates symptom severity, you must establish a medically determinable impairment under 20 CFR 404.1521. Disability cannot be based solely on self-reported symptoms such as pain or fatigue. The agency requires objective medical evidence from an acceptable medical source, such as a licensed physician or rheumatologist, under 20 CFR 404.1513.

To confirm systemic sclerosis, SSA reviews laboratory findings and objective clinical notes. Clinically accepted serological tests include antinuclear antibodies (ANA), anti-topoisomerase I (anti-Scl-70), anticentromere antibodies (ACA), and anti-RNA polymerase III antibodies. Physical examinations must document classic features, such as skin thickening, sclerodactyly of the fingers, telangiectasias, calcinosis, or severe Raynaud's phenomenon. Once confirmed, your claim moves through the five-step sequential evaluation process outlined in 20 CFR 404.1520.

Meeting Blue Book Listing 14.04 for Systemic Sclerosis

At Step 3, SSA checks whether your condition meets or medically equals a listing in 20 CFR Part 404, Subpart P, Appendix 1. Adult systemic sclerosis is evaluated under Listing 14.04 in Section 14.00 for immune system disorders. Listing 14.04 provides three distinct evaluation pathways. Meeting any one of these criteria results in approval on medical grounds alone.

Listing 14.04A: Multi-Organ Involvement with Constitutional Symptoms

Listing 14.04A requires documented involvement of two or more organs or body systems. At least one of the affected organs or systems must reach at least a moderate level of severity.

In addition, your medical record must document at least two constitutional symptoms or signs that persist over time under Section 14.00C8:

• Severe fatigue, defined as frequent profound exhaustion causing significant reduction in activity.
• Fever, documented by clinical temperature readings.
• Malaise, defined as frequent bodily discomfort or lethargy that inhibits normal daily functioning.
• Involuntary weight loss, confirmed by serial weight measurements in medical progress notes.

If your records show moderate impairment of your lungs or digestive tract combined with documented severe fatigue and involuntary weight loss, your claim satisfies Listing 14.04A.

Listing 14.04B: Specific Physical, Vascular, or Organ Impairments

Listing 14.04B provides an approval pathway based on specific anatomical deformities, severe vascular complications, or irreversible organ damage. You can satisfy Listing 14.04B by meeting any one of the following:

• Generalized scleroderma with skin thickening extending proximal to the elbows or knees, involving the trunk.
• Raynaud's phenomenon with gangrene in at least two extremities.
• Raynaud's phenomenon with digital ischemia and persistent ulcerations of the fingers or toes, causing an inability to perform fine and gross movements effectively under Section 14.00C6.
• Irreversible damage to the respiratory system, evaluated under Section 3.00, such as diffuse interstitial fibrosis or pulmonary arterial hypertension.
• Irreversible damage to the cardiovascular system, evaluated under Section 4.00, such as arrhythmias, pericarditis, or heart failure.
• Irreversible damage to the digestive system, evaluated under Section 5.00, including severe esophageal dysmotility or chronic intestinal pseudo-obstruction.
• Irreversible damage to the kidneys, evaluated under Section 6.00, including chronic renal failure or damage from scleroderma renal crisis.

Under Section 14.00C6, the inability to perform fine and gross movements effectively means an extreme loss of function in both upper extremities, such as an inability to prepare a simple meal, feed oneself, or turn a doorknob with either hand.

Listing 14.04C: Repeated Manifestations and Marked Limitations

Listing 14.04C applies to claimants whose disease causes intermittent flares and functional decline. You must establish repeated manifestations of systemic sclerosis, along with at least two constitutional symptoms (severe fatigue, fever, malaise, or involuntary weight loss).

Under Section 14.00I3, repeated manifestations mean flares occurring on average at least three times a year, or once every four months, each lasting at least two weeks. Flares can also qualify if they occur more frequently for shorter periods, or less frequently if each episode lasts substantially longer than two weeks.

Furthermore, your condition must result in a marked limitation in at least one of three functional areas under Section 14.00I5:

• Activities of daily living, such as dressing, bathing, cooking, or managing household chores.
• Maintaining social functioning, including communicating effectively and interacting appropriately with others.
• Completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace.

Qualifying Through Residual Functional Capacity

Many people with systemic sclerosis experience disabling pain and stiffness without meeting the exact clinical thresholds of Listing 14.04. If your condition does not meet or equal a listing, SSA assesses your Residual Functional Capacity (RFC) under 20 CFR 404.1545.

Your RFC measures the most physical and mental work you can sustain on a regular 40-hour workweek schedule. SSA evaluates your treatment records, physician opinions, and symptom statements under 20 CFR 404.1529.

Manipulative and Hand Limitations

Scleroderma frequently attacks the hands and wrists first. Skin tightening, calcinosis deposits, and joint contractures often make sustained manipulative tasks impossible.

Under Social Security Ruling SSR 83-10, most unskilled sedentary jobs require bilateral manual dexterity for fine fingering and handling. If your medical records document that you cannot grasp objects, type, or pick up small items for extended periods, you cannot perform the full range of sedentary work. Bilateral manual restrictions eliminate most clerical and assembly jobs.

Environmental and Physical Restrictions

Raynaud's phenomenon causes painful vasospasm of the digital blood vessels when exposed to cold temperatures or stress. This triggers severe blanching, cyanosis, pain, and numbness in the fingers and toes.

Adjudicators must reflect environmental limits in your RFC. An RFC for scleroderma often requires complete avoidance of cold working environments, refrigerated spaces, rapid temperature changes, and vibrating machinery. These restrictions eliminate outdoor positions, refrigerated warehouse jobs, and factory assembly work.

Pulmonary complications like interstitial lung disease cause shortness of breath on minimal exertion, restricting standing and walking to less than two hours daily. Gastrointestinal dysmotility causes chronic dysphagia and gastroparesis, necessitating frequent unscheduled restroom breaks. Chronic pain and fatigue also cause workers to drift off-task. Vocational testimony confirms that being off-task beyond normal workplace tolerances, or missing two or more workdays monthly, eliminates competitive employment.

Vocational Evaluation at Steps 4 and 5

Once SSA determines your RFC, it proceeds to Step 4 to evaluate whether you can perform your past relevant work under 20 CFR 404.1565. Past relevant work covers work performed within the past 15 years at substantial gainful activity levels.

If you cannot perform past work, SSA moves to Step 5. The agency must show that other jobs exist in significant numbers in the national economy that you can perform, considering your RFC, age, education, and skills.

SSA applies the Medical-Vocational Guidelines in 20 CFR Part 404, Subpart P, Appendix 2. For claimants age 50 or older who are limited to sedentary work and lack transferable skills, these grid rules often direct an approval.

Non-Medical Eligibility Requirements

In addition to medical severity, you must satisfy basic technical rules to receive SSDI benefits:

• Substantial Gainful Activity (SGA): Under 20 CFR 404.1574, you cannot work above the SGA earnings limit. In 2026, the monthly SGA cap is $1,690 for non-blind individuals and $2,830 for statutorily blind individuals in 2026. Earning above this limit triggers a technical denial at Step 1.
• Duration Requirement: Under 20 CFR 404.1509, your condition must have lasted or be expected to last for a continuous period of at least 12 months, or result in death.
• Insured Status: Under 20 CFR 404.130, you must have earned sufficient work credits. In 2026, you earn one work credit for every $1,810 in covered earnings, up to four credits in 2026. Most claimants need 20 credits earned in the 10 years before disability began.

Application procedures and appeals are distinct stages covered elsewhere and are outside the scope of this article.

Frequently Asked Questions

Can you get SSDI for systemic sclerosis or scleroderma? Yes, you can qualify for SSDI if your scleroderma satisfies the medical criteria of Blue Book Listing 14.04 or reduces your functional capacity so much that you cannot perform any full-time work.

What medical tests does SSA look for to confirm scleroderma? SSA requires objective clinical evidence from an acceptable medical source, including positive autoantibody tests such as ANA, anti-Scl-70, or anticentromere antibodies, alongside physical documentation of skin thickening or digital ulcers.

What if my scleroderma does not meet Listing 14.04? If your condition does not meet the exact listing, SSA assesses your residual functional capacity under 20 CFR 404.1545 to determine whether your hand limitations, fatigue, pain, and environmental restrictions prevent all sustained employment.

This article is general information about SSDI eligibility, not legal advice. Program rules and evaluation policies change over time, and every case turns on its own medical evidence. Consult a qualified representative or contact SSA directly for guidance on a specific claim.